Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option.
KFF: 77% of Women Are In Favor of Over-the-counter Birth Control Pills
The main factor behind why women want over-the-counter birth control pills is convenience, the survey found. Of those who are unlikely to use over-the-counter birth control pills — or are unsure if they would —most said it's because they don’t currently use birth control pills or don’t plan to in the future.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.